“Canada at the Forefront” edition, Stream Neurosciences feature
BIOTECanada Insights magazine — Spring 2026
Discovery of Novel Benzothiazole-Based PDE4 Inhibitors for Central Nervous System Disorders.
Meng L, Liang SH — 6 April 2026 (issue 14 May 2026)
Northern Illinois University and Stream Neuroscience report PDE4 inhibitors
BioWorld Science — 8 October 2025
Zebrafish: Breakthroughs In Epilepsy Drug Discovery?!
Neuroscientist Prof. Deborah Kurrasch from the University of Calgary talks about her research into the epilepsies using zebrafish!
Bringing ‘One Brain’ research to market for better brain health
University of Calgary news release — 19 April 2018
UCalgary researchers use new approach in precision medicine to screen anti-seizure drugs for children”
Education News Canada, University of Calgary
Stream Neuroscience co-founder & CEO speaks about clinical utility of brain organoid research for drug discovery.
Publication is no longer available online
Stream Neuroscience co-founder & CEO panelist at NEUROVATION: Scientist to Entrepreneur Panel,
This panel will feature researchers from HBI who have gone on to launch biotech startups from their research. They will share insights into their journeys, their discoveries, how they created a product, and how they are developing that product to benefit the community. They will also share some lessons learned along the way. Read on […]
Stream Neuroscience co-founder and CEO invited speaker at EMBO (Karnataka, India)
Presenting on the use of brain organoids to study Dravet Syndrome.
Stream Neuroscience co-founder & CEO presents at Banff International Epilepsy Symposium (Banff, AB) on pipelines to new anti-seizure drug therapies.
The 4th Banff International Epilepsy Symposium, a satellite event of the 2nd North American Epilepsy Congress, will take place in a virtual format on 6 May 2022.